vs

Side-by-side financial comparison of COMERICA INC (CMA) and Genius Sports Ltd (GENI). Click either name above to swap in a different company.

COMERICA INC is the larger business by last-quarter revenue ($838.0M vs $510.9M, roughly 1.6× Genius Sports Ltd). COMERICA INC runs the higher net margin — 21.0% vs -12.3%, a 33.3% gap on every dollar of revenue. Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs 108.9%).

Comerica Incorporated is an American financial services company, headquartered in Dallas, Texas. It is the parent of Comerica Bank, a regional commercial bank with 413 branches in the U.S. states of Texas, Michigan, California, Florida and Arizona. Comerica is among the largest U.S. financial holding companies, with offices in a number of U.S. cities.

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

CMA vs GENI — Head-to-Head

Bigger by revenue
CMA
CMA
1.6× larger
CMA
$838.0M
$510.9M
GENI
Higher net margin
CMA
CMA
33.3% more per $
CMA
21.0%
-12.3%
GENI
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
108.9%
CMA

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
CMA
CMA
GENI
GENI
Revenue
$838.0M
$510.9M
Net Profit
$176.0M
$-63.0M
Gross Margin
25.2%
Operating Margin
-11.5%
Net Margin
21.0%
-12.3%
Revenue YoY
3.3%
Net Profit YoY
-4.3%
EPS (diluted)
$1.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMA
CMA
GENI
GENI
Q4 25
$510.9M
Q3 25
$838.0M
$335.4M
Q2 25
$849.0M
$215.2M
Q1 25
$829.0M
$119.7M
Q4 24
$825.0M
$413.0M
Q3 24
$811.0M
$285.8M
Q2 24
$824.0M
$184.1M
Q1 24
$784.0M
$97.2M
Net Profit
CMA
CMA
GENI
GENI
Q4 25
$-63.0M
Q3 25
$176.0M
Q2 25
$199.0M
$-47.3M
Q1 25
$172.0M
$-25.5M
Q4 24
$170.0M
$-85.5M
Q3 24
$184.0M
$-47.1M
Q2 24
$206.0M
$-35.5M
Q1 24
$138.0M
$-25.2M
Gross Margin
CMA
CMA
GENI
GENI
Q4 25
25.2%
Q3 25
24.2%
Q2 25
19.1%
Q1 25
10.7%
Q4 24
16.7%
Q3 24
20.5%
Q2 24
18.6%
Q1 24
9.8%
Operating Margin
CMA
CMA
GENI
GENI
Q4 25
-11.5%
Q3 25
-15.3%
Q2 25
-21.0%
Q1 25
-20.3%
Q4 24
-18.0%
Q3 24
-13.9%
Q2 24
-16.8%
Q1 24
-23.7%
Net Margin
CMA
CMA
GENI
GENI
Q4 25
-12.3%
Q3 25
21.0%
Q2 25
23.4%
-22.0%
Q1 25
20.7%
-21.3%
Q4 24
20.6%
-20.7%
Q3 24
22.7%
-16.5%
Q2 24
25.0%
-19.3%
Q1 24
17.6%
-25.9%
EPS (diluted)
CMA
CMA
GENI
GENI
Q4 25
Q3 25
$1.35
Q2 25
$1.42
Q1 25
$1.25
Q4 24
$1.22
Q3 24
$1.33
Q2 24
$1.49
Q1 24
$0.98

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMA
CMA
GENI
GENI
Cash + ST InvestmentsLiquidity on hand
$280.6M
Total DebtLower is stronger
$5.4B
Stockholders' EquityBook value
$7.4B
$724.5M
Total Assets
$77.4B
$1.1B
Debt / EquityLower = less leverage
0.73×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMA
CMA
GENI
GENI
Q4 25
$280.6M
Q3 25
$110.2M
Q2 25
$110.2M
Q1 25
$110.2M
Q4 24
$100.3M
Q3 24
$100.3M
Q2 24
$100.3M
Q1 24
$100.3M
Total Debt
CMA
CMA
GENI
GENI
Q4 25
Q3 25
$5.4B
Q2 25
$5.8B
Q1 25
$5.7B
Q4 24
$6.7B
Q3 24
$6.8B
Q2 24
$7.1B
Q1 24
$7.1B
Stockholders' Equity
CMA
CMA
GENI
GENI
Q4 25
$724.5M
Q3 25
$7.4B
$572.4M
Q2 25
$6.9B
$572.4M
Q1 25
$7.1B
$572.4M
Q4 24
$6.5B
$573.0M
Q3 24
$7.4B
$573.0M
Q2 24
$6.2B
$573.0M
Q1 24
$6.0B
$573.0M
Total Assets
CMA
CMA
GENI
GENI
Q4 25
$1.1B
Q3 25
$77.4B
$792.3M
Q2 25
$78.0B
$792.3M
Q1 25
$77.6B
$792.3M
Q4 24
$79.3B
$775.7M
Q3 24
$79.7B
$775.7M
Q2 24
$79.6B
$775.7M
Q1 24
$79.4B
$775.7M
Debt / Equity
CMA
CMA
GENI
GENI
Q4 25
Q3 25
0.73×
Q2 25
0.84×
Q1 25
0.81×
Q4 24
1.02×
Q3 24
0.92×
Q2 24
1.15×
Q1 24
1.18×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMA
CMA
GENI
GENI
Operating Cash FlowLast quarter
$-270.0M
$81.9M
Free Cash FlowOCF − Capex
$69.6M
FCF MarginFCF / Revenue
13.6%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
-1.53×
TTM Free Cash FlowTrailing 4 quarters
$33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMA
CMA
GENI
GENI
Q4 25
$81.9M
Q3 25
$-270.0M
$-4.8M
Q2 25
$476.0M
$-1.2M
Q1 25
$273.0M
$-14.6M
Q4 24
$601.0M
$14.9M
Q3 24
$1.0B
$-9.2M
Q2 24
$111.0M
Q1 24
$-205.0M
Free Cash Flow
CMA
CMA
GENI
GENI
Q4 25
$69.6M
Q3 25
$-14.2M
Q2 25
$-5.8M
Q1 25
$-16.0M
Q4 24
$11.3M
Q3 24
$-11.6M
Q2 24
Q1 24
FCF Margin
CMA
CMA
GENI
GENI
Q4 25
13.6%
Q3 25
-4.2%
Q2 25
-2.7%
Q1 25
-13.4%
Q4 24
2.7%
Q3 24
-4.1%
Q2 24
Q1 24
Capex Intensity
CMA
CMA
GENI
GENI
Q4 25
2.4%
Q3 25
2.8%
Q2 25
2.1%
Q1 25
1.2%
Q4 24
0.9%
Q3 24
0.9%
Q2 24
Q1 24
Cash Conversion
CMA
CMA
GENI
GENI
Q4 25
Q3 25
-1.53×
Q2 25
2.39×
Q1 25
1.59×
Q4 24
3.54×
Q3 24
5.70×
Q2 24
0.54×
Q1 24
-1.49×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons